October 26, 2007 - The Mattson Jack Group Inc. today released its Comorbidity Database designed to help clients make strategic decisions based on an in-depth understanding of the importance of mutually exclusive and overlapping conditions.
The Comorbidity Database consists of two modules: Comorbidity Database - CNS 2.0, which focuses on mental health disorders, and Comorbidity Database - Med 2.0, which features a broad range of medical diagnoses and risk factors, excluding mental health disorders.
The Comorbidity Database will provide patient numbers for mutually exclusive segments for any combination of disorders and diagnostic categories. The company says pharmaceutical companies can use this information to build accurate market forecasts, identify patient subgroups by various risk factors, and analyze overlaps of subgroup populations.
The Comorbidity Database product offerings exemplify MattsonJack’s commitment to epidemiology and continuous product enhancement. Additional information on disorders or conditions covered by each module, data sources, and additional enhancements can be found on MattsonJack’s Web site.
For more information: www.mattsonjack.com